Tau protein, oxidative stress and glycosaminoglycan mimetics. Links for new therapeutic possibilities in Alzheimer’s disease

Tau protein, oxidative stress and glycosaminoglycan mimetics. Links for new therapeutic possibilities in Alzheimer’s disease

Pas de résumé français === Pas de résumé anglais

Bibliographic Details
Main Author:	Zhang, Ganlin
Other Authors:	Paris Est
Language:	fr
Published:	2011
Subjects:	Apoptose Protéine tau Glycannes sulfatés Alzheimer Apoptosis Tau protein Glycans
Online Access:	http://www.theses.fr/2011PEST0104

Similar Items

PET Imaging of Tau Pathology: Towards an affirmative diagnosis of Alzheimer’s and Tauopathies
by: Olga eJames, et al.
Published: (2015-03-01)

Microfluidic Protein Imaging Platform: Study of Tau Protein Aggregation and Alzheimer’s Drug Response
by: Shubha Jain, et al.
Published: (2020-12-01)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
by: Robert Y. K. Lai, et al.
Published: (2016-04-01)

New Therapeutic Targets in Alzheimer's Disease
by: Horia Coman, et al.
Published: (2017-03-01)

Development and validation of a salivary tau biomarker in Alzheimer's disease
by: Heather Pekeles, et al.
Published: (2018-01-01)

Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease
by: Xi-Lin Wu, et al.
Published: (2017-01-01)

The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer's disease.
by: Paola eFlores-Rodríguez, et al.
Published: (2015-02-01)

A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer’s Disease
by: Rubayat Islam Khan, et al.
Published: (2018-08-01)

Serum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer’s Disease Progression
by: Eunjoo Nam, et al.
Published: (2020-07-01)

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
by: Jakub Sinsky, et al.
Published: (2021-08-01)

A possible link between astrocyte activation and tau nitration in Alzheimer's disease
by: Juan F. Reyes, et al.
Published: (2008-08-01)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
by: Yan Zhou, et al.
Published: (2018-02-01)

Tau-mediated synaptic damage in Alzheimer’s disease
by: Jadhav Santosh, et al.
Published: (2015-01-01)

Étude de la toxicité neuronale induite par la protéine Tau dans la maladie d’Alzheimer, sur un modèle Invertébré : Drosophila melanogaster
by: Talmat-Amar, Yasmina
Published: (2012)

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
by: Nicolas R. Barthélemy, et al.
Published: (2020-03-01)

FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments
by: Senthilvelrajan Kaniyappan, et al.
Published: (2020-07-01)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
by: Abdullah Al Mamun, et al.
Published: (2020-01-01)

Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis
by: Wen Hu, et al.
Published: (2017-09-01)

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
by: Yuxing Xia, et al.
Published: (2020-06-01)

Studies on the Role of Cellular Heparan Sulfate on Tau Pathology in Alzheimer's Disease and Related Tauopathies
by: Sepulveda-Diaz, Julia
Published: (2013)

Propagation of Tau via Extracellular Vesicles
by: Mar Pérez, et al.
Published: (2019-07-01)

Modulation der Tau-Aggregation durch Modifikation der Cystein-Reste im Tau-Protein
by: Karras, Stephanie
Published: (2017)

Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
by: Vanessa de Jesus R. de Paula, et al.

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
by: Jin Miao, et al.
Published: (2019-03-01)

Astrocytic Propagation of Tau in the Context of Alzheimer's Disease
by: Rebecca M. Fleeman, et al.
Published: (2021-03-01)

Inhibiteurs et modèles moléculaires de fibres amyloïdes ° et tau impliquées dans la maladie d'Alzheimer : conception, synthèse et caractérisation
by: Dufour, Emilie
Published: (2013)

Fonctions atypiques de Tau en conditions physiologique et pathologique
by: Violet, Marie
Published: (2014)

Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model
by: Sarah Houben, et al.
Published: (2019-07-01)

Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2018-03-01)

Approche d'immunothérapie dans un modèle murin de pathologie Tau
by: Troquier-Péricou, Laetitia
Published: (2011)

The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
by: Rafaella Araujo Gonçalves, et al.
Published: (2019-02-01)

De la cellule au primate, propagation physiopathologique de la protéine Tau
by: Dujardin, Simon
Published: (2015)

The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease
by: Sarah C. Hopp, et al.
Published: (2018-09-01)

N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
by: Kerstin Schlegel, et al.
Published: (2019-11-01)

Tau protein aggregation and α-synuclein dysfunction : development of new in vitro and in vivo models to study neurodegenerative diseases
by: Roman, Andrei
Published: (2018)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01)

Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease
by: Mandić Gorana, et al.
Published: (2008-01-01)

Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies
by: Benjamin Combs, et al.
Published: (2016-10-01)

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation
by: Shweta Kishor Sonawane, et al.
Published: (2021-02-01)

Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology
by: Antoine Duquette, et al.
Published: (2021-01-01)